You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 191 No. 4, January 25, 1965 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pigmentation Due to Phenothiazines in High and Prolonged Dosage

Abraham Satanove, MD

JAMA. 1965;191(4):263-268.


Abstract

Seventy-eight patients receiving abnormally high doses of chlorpromazine and related phenothiazine derivatives for prolonged periods developed pigmentary changes in the exposed areas of the skin after exposure to specific bands of sunlight. Histochemical studies suggested that this color was melanin or a melanin-like substance. The phototoxic action of sunlight acting on the abnormal amounts of the phenothiazines in the skin produced an inflammatory response followed by increased production of melanin. The accumulation of melanin, or melanin plus chlorpromazine or its metabolites, is thought to cause the purple color. The skin-window technique demonstrated a sequence of inflammatory cells which transport the pigment to the bloodstream. It is postulated that the cellular transportation of the pigment from the skin into the bloodstream may produce the generalized melanosis found on autopsy.



Author Affiliations

From the Provincial Mental Hospital and Crease Clinic, Essondale, BC, Canada.


Footnotes

Read before the 18th Canadian Dermatological Association Meeting, June 27, 1964, Vancouver, BC.

Reprint requests to Box 25, Essondale, BC, Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Desipramine-Induced Blue-Gray Photosensitive Pigmentation
Narurkar et al.
Arch Dermatol 1993;129:474-476.
ABSTRACT  

Exposure to Phenothiazine Drugs and Risk of Cataract
Isaac et al.
Arch Ophthalmol 1991;109:256-260.
ABSTRACT  

Microprobe Analysis of Chlorpromazine Pigmentation
Benning et al.
Arch Dermatol 1988;124:1541-1544.
ABSTRACT  

The Lens and Vitreous
Winter
Arch Ophthalmol 1967;78:229-255.
 

The Current Status of Phenothiazines
Kinross-Wright
JAMA 1967;200:461-464.
ABSTRACT  

Phototoxic Reactions Induced by High Doses of Chlorpromazine and Thioridazine
Satanove and McIntosh
JAMA 1967;200:209-212.
ABSTRACT  

Skin Changes and Chlorpromazine: Some Hazards of Long-Term Drug Therapy
Zelickson
JAMA 1966;198:341-344.
ABSTRACT  

Persistent Dyskinesias Following Phenothiazine Therapy: Report of Five Cases and a Review of the Literature
SCHMIDT and JARCHO
Arch Neurol 1966;14:369-377.
ABSTRACT  

Ocular Manifestations of Chronic Phenothiazine Derivative Administration
McCLANAHAN et al.
Arch Ophthalmol 1966;75:319-325.
ABSTRACT  

Lids, Lacrimal Apparatus, and Conjunctiva
BURNS
Arch Ophthalmol 1965;74:850-867.
 

Skin Pigmentation and Chlorpromazine
Zelickson
JAMA 1965;194:670-672.
ABSTRACT  

The Ocular Toxic Findings With Prolonged and High Dosage Chlorpromazine Intake
SIDDALL
Arch Ophthalmol 1965;74:460-464.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.